Today: 3 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow stock slips before earnings as Fed holds rates — what to watch in NOW shares

ServiceNow shares fell 1.2% to $130.24 Wednesday afternoon as investors awaited quarterly earnings due after the bell. Wall Street focused on subscription growth and backlog, with analysts expecting revenue of $3.53 billion, up 19% year-over-year. The Fed held rates steady, pressuring tech stocks. ServiceNow recently expanded its AI partnership with OpenAI.
28 January 2026
···
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.
28 January 2026
·
Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

Coinbase stock edges up as UK bans ‘Everything is Fine’ ads and prediction markets draw heat

Coinbase shares rose 0.2% to $211.24 Wednesday after UK regulators banned a Coinbase ad campaign over crypto risk messaging tied to cost-of-living concerns. The company is expanding into stock trading and event contracts as regulatory scrutiny intensifies. Coinbase’s next earnings report is due Feb. 12. Bitcoin climbed 1.3% to about $89,294.
28 January 2026
··
Starbucks stock swings after earnings pop — what investors watch at Niccol’s investor day

Starbucks stock swings after earnings pop — what investors watch at Niccol’s investor day

Starbucks shares rose 1% to $96.56 after swinging more than 10% following Q1 results showing 4% global same-store sales growth and first U.S. increase in two years. Margins fell for the eighth straight quarter, frustrating investors. CEO Brian Niccol cited new drinks as growth drivers but warned service targets will take time. All eyes turn to Thursday’s investor day for margin guidance.
28 January 2026
·
Chevron stock price: CVX inches up after report flags March jump in Venezuelan crude exports

Chevron stock price: CVX inches up after report flags March jump in Venezuelan crude exports

Chevron shares rose 0.3% to $169.48 after reports it plans to raise Venezuelan crude exports to the U.S. to 300,000 barrels per day in March. Brent crude climbed 1.1% to $68.33 a barrel. U.S. officials are preparing a general license for Venezuela’s energy sector, sources said. Chevron also named Thomas W. Horton to its board and will report Q4 earnings Jan. 30.
28 January 2026
··
AT&T stock jumps on upbeat 2026 outlook and $45B return plan — fiber deals in focus

AT&T stock jumps on upbeat 2026 outlook and $45B return plan — fiber deals in focus

AT&T shares rose 4.9% to $24.14 Wednesday after reporting a 3.6% revenue increase to $33.5 billion for the fourth quarter and $4.2 billion in free cash flow. The company reaffirmed plans to return over $45 billion to shareholders through 2028 and projected at least $18 billion in free cash flow by 2026. Trading volume topped 52 million shares. Investors watched pending fiber and spectrum deals and signs of easing wireless churn.
28 January 2026
···
Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson stock rises on Darzalex Faspro FDA nod as traders size up drug-pricing risks

Johnson & Johnson shares rose 1.2% to $227.06 after the FDA approved Darzalex Faspro for use with the VRd regimen in newly diagnosed multiple myeloma patients ineligible for stem cell transplant. The approval is based on the CEPHEUS trial, which showed improved outcomes. The move comes as Medicare named 15 drugs for future price negotiations, pressuring the sector.
28 January 2026
··
Constellation Energy stock edges lower as PJM power prices spike in deep freeze — what to watch next for CEG

Constellation Energy stock edges lower as PJM power prices spike in deep freeze — what to watch next for CEG

Constellation Energy shares slipped 0.2% to $288.12 Wednesday as PJM Interconnection reported spot power prices above $1,000/MWh in parts of the Mid-Atlantic amid cold-driven grid strain. About 1.6 million shares traded. PJM cited nearly 21 GW of generation outages and warned of possible controlled outages. Constellation recently completed its Calpine acquisition and awaits an earnings report projected for Feb. 17.
28 January 2026
··
Abbott Laboratories stock price slides as Argus cuts target and CEO Ford discloses share buy

Abbott Laboratories stock price slides as Argus cuts target and CEO Ford discloses share buy

Abbott Laboratories shares fell about 2% to $106.12 Wednesday after Argus cut its price target to $140, following last week’s earnings warning. CEO Robert Ford bought 18,800 shares on Jan. 23 at an average $107.13, according to an SEC filing. The broader healthcare sector slipped ahead of the Federal Reserve’s rate decision. Abbott cited weak nutrition and diagnostics sales and higher costs for its recent profit miss.
28 January 2026
·
Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health ELV stock price jumps 6% after earnings, but 2026 outlook points to revenue dip

Elevance Health shares jumped 6% to $343.14 Wednesday after the company set a 2026 profit floor despite warning of lower revenue. The move followed a $80 billion sector selloff triggered by new Medicare payment proposals. Elevance projected 2026 adjusted earnings of at least $25.50 per share and year-end enrollment up to 43.875 million. Fourth-quarter operating revenue reached $49.3 billion.
28 January 2026
··
Nvidia stock price rises on China H200 nod as AI chip shares keep Wall Street near 7,000

Nvidia stock price rises on China H200 nod as AI chip shares keep Wall Street near 7,000

Nvidia shares rose 1.7% after China approved ByteDance, Alibaba, and Tencent to buy over 400,000 H200 AI chips, though no orders have been placed due to strict conditions. Intel and Micron led a rally in chip stocks as investors awaited Fed and Big Tech earnings. Micron announced a $24 billion memory chip plant in Singapore. SK Hynix and ASML both reported record results on AI demand.
28 January 2026
·········
Gold price breaks $5,300 record before Fed decision, lifting GLD and miners

Gold price breaks $5,300 record before Fed decision, lifting GLD and miners

Gold prices hit a record $5,311 an ounce Wednesday as the U.S. dollar rebounded from a two-year low ahead of the Federal Reserve’s policy announcement. Spot gold rose 1.9% to $5,289.48 by midday, while February futures gained 4%. Retail demand spiked in Asia, with crowds reported at gold shops in Shanghai and Hong Kong. Traders awaited Fed Chair Jerome Powell’s remarks for signals on interest rates.
28 January 2026
···
Texas Instruments stock jumps nearly 10% as AI data-center demand lifts chipmakers

Texas Instruments stock jumps nearly 10% as AI data-center demand lifts chipmakers

Texas Instruments shares rose nearly 10% after forecasting stronger-than-expected first-quarter revenue, citing surging demand for analog chips in AI data centers. Seagate jumped almost 20% on a bullish storage outlook, while Intel gained close to 11%. Investors awaited the Federal Reserve’s policy decision and major tech earnings due Wednesday. ASML reported record Q4 orders and plans 1,700 job cuts.
28 January 2026
······
1 … 213 214 215 216 217 … 732

Stock Market Today

  • Stock Market Faces Extended 'Trump Slump' Amid Iran Conflict and High Valuations
    April 3, 2026, 4:25 AM EDT. The U.S. stock market, despite strong gains during Donald Trump's first term, has entered a turbulent phase in his second term, dubbed the 'Trump slump.' Since late February, major indexes like the Dow and Nasdaq have fallen into correction territory. Contributing factors include historically high valuations, reflected by the S&P 500's Shiller Price-to-Earnings Ratio at its second-highest level ever, and concerns over a potential artificial intelligence (AI) bubble burst. Critically, Trump's directive initiating U.S. and Israeli military action against Iran has led to the closure of the strategic Strait of Hormuz, through which about 20% of the world's oil passes. This supply shock has sent crude oil prices soaring, further pressuring markets and possibly forcing the Federal Reserve to react, extending the current equity downturn.
Go toTop